338 related articles for article (PubMed ID: 17851451)
21. Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: report from the constitutional mismatch repair deficiency consortium.
Bakry D; Aronson M; Durno C; Rimawi H; Farah R; Alharbi QK; Alharbi M; Shamvil A; Ben-Shachar S; Mistry M; Constantini S; Dvir R; Qaddoumi I; Gallinger S; Lerner-Ellis J; Pollett A; Stephens D; Kelies S; Chao E; Malkin D; Bouffet E; Hawkins C; Tabori U
Eur J Cancer; 2014 Mar; 50(5):987-96. PubMed ID: 24440087
[TBL] [Abstract][Full Text] [Related]
22. PMS2 involvement in patients suspected of Lynch syndrome.
Niessen RC; Kleibeuker JH; Westers H; Jager PO; Rozeveld D; Bos KK; Boersma-van Ek W; Hollema H; Sijmons RH; Hofstra RM
Genes Chromosomes Cancer; 2009 Apr; 48(4):322-9. PubMed ID: 19132747
[TBL] [Abstract][Full Text] [Related]
23. Diversity of the clinical presentation of the MMR gene biallelic mutations.
Bougeard G; Olivier-Faivre L; Baert-Desurmont S; Tinat J; Martin C; Bouvignies E; Vasseur S; Huet F; Couillault G; Vabres P; Le Pessot F; Chapusot C; Malka D; Bressac-de Paillerets B; Tosi M; Frebourg T
Fam Cancer; 2014 Mar; 13(1):131-5. PubMed ID: 24068316
[TBL] [Abstract][Full Text] [Related]
24. A homozygous MSH6 mutation in a child with café-au-lait spots, oligodendroglioma and rectal cancer.
Menko FH; Kaspers GL; Meijer GA; Claes K; van Hagen JM; Gille JJ
Fam Cancer; 2004; 3(2):123-7. PubMed ID: 15340263
[TBL] [Abstract][Full Text] [Related]
25. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.
Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL
J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158
[TBL] [Abstract][Full Text] [Related]
26. Constitutive deficiency in DNA mismatch repair.
Felton KE; Gilchrist DM; Andrew SE
Clin Genet; 2007 Jun; 71(6):483-98. PubMed ID: 17539897
[TBL] [Abstract][Full Text] [Related]
27. Compound heterozygosity for two MSH6 mutations in a patient with early onset of HNPCC-associated cancers, but without hematological malignancy and brain tumor.
Plaschke J; Linnebacher M; Kloor M; Gebert J; Cremer FW; Tinschert S; Aust DE; von Knebel Doeberitz M; Schackert HK
Eur J Hum Genet; 2006 May; 14(5):561-6. PubMed ID: 16418736
[TBL] [Abstract][Full Text] [Related]
28. Constitutive deficiency in DNA mismatch repair: is it time for Lynch III?
Felton KE; Gilchrist DM; Andrew SE
Clin Genet; 2007 Jun; 71(6):499-500. PubMed ID: 17539898
[TBL] [Abstract][Full Text] [Related]
29. Germ line mutations of mismatch repair genes in hereditary nonpolyposis colorectal cancer patients with small bowel cancer: International Society for Gastrointestinal Hereditary Tumours Collaborative Study.
Park JG; Kim DW; Hong CW; Nam BH; Shin YK; Hong SH; Kim IJ; Lim SB; Aronson M; Bisgaard ML; Brown GJ; Burn J; Chow E; Conrad P; Douglas F; Dunlop M; Ford J; Greenblatt MS; Heikki J; Heinimann K; Lynch EL; Macrae F; McKinnon WC; Möeslein G; Rossi BM; Rozen P; Schofield L; Vaccaro C; Vasen H; Velthuizen M; Viel A; Wijnen J;
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3389-93. PubMed ID: 16740762
[TBL] [Abstract][Full Text] [Related]
30. Hypothesis: Possible role of retinoic acid therapy in patients with biallelic mismatch repair gene defects.
Gottschling S; Reinhard H; Pagenstecher C; Krüger S; Raedle J; Plotz G; Henn W; Buettner R; Meyer S; Graf N
Eur J Pediatr; 2008 Feb; 167(2):225-9. PubMed ID: 17387511
[TBL] [Abstract][Full Text] [Related]
31. Lynch syndrome caused by germline PMS2 mutations: delineating the cancer risk.
ten Broeke SW; Brohet RM; Tops CM; van der Klift HM; Velthuizen ME; Bernstein I; Capellá Munar G; Gomez Garcia E; Hoogerbrugge N; Letteboer TG; Menko FH; Lindblom A; Mensenkamp AR; Moller P; van Os TA; Rahner N; Redeker BJ; Sijmons RH; Spruijt L; Suerink M; Vos YJ; Wagner A; Hes FJ; Vasen HF; Nielsen M; Wijnen JT
J Clin Oncol; 2015 Feb; 33(4):319-25. PubMed ID: 25512458
[TBL] [Abstract][Full Text] [Related]
32. A homozygous PMS2 founder mutation with an attenuated constitutional mismatch repair deficiency phenotype.
Li L; Hamel N; Baker K; McGuffin MJ; Couillard M; Gologan A; Marcus VA; Chodirker B; Chudley A; Stefanovici C; Durandy A; Hegele RA; Feng BJ; Goldgar DE; Zhu J; De Rosa M; Gruber SB; Wimmer K; Young B; Chong G; Tischkowitz MD; Foulkes WD
J Med Genet; 2015 May; 52(5):348-52. PubMed ID: 25691505
[TBL] [Abstract][Full Text] [Related]
33. Nine novel pathogenic germline mutations in MLH1, MSH2, MSH6 and PMS2 in families with Lynch syndrome.
Rahner N; Friedrichs N; Wehner M; Steinke V; Aretz S; Friedl W; Buettner R; Mangold E; Propping P; Walldorf C
Acta Oncol; 2007; 46(6):763-9. PubMed ID: 17653898
[TBL] [Abstract][Full Text] [Related]
34. Phenotypic and genotypic characterisation of biallelic mismatch repair deficiency (BMMR-D) syndrome.
Durno CA; Sherman PM; Aronson M; Malkin D; Hawkins C; Bakry D; Bouffet E; Gallinger S; Pollett A; Campbell B; Tabori U;
Eur J Cancer; 2015 May; 51(8):977-83. PubMed ID: 25883011
[TBL] [Abstract][Full Text] [Related]
35. Multiple pilomatricomas with somatic CTNNB1 mutations in children with constitutive mismatch repair deficiency.
Chmara M; Wernstedt A; Wasag B; Peeters H; Renard M; Beert E; Brems H; Giner T; Bieber I; Hamm H; Sciot R; Wimmer K; Legius E
Genes Chromosomes Cancer; 2013 Jul; 52(7):656-64. PubMed ID: 23629955
[TBL] [Abstract][Full Text] [Related]
36. Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC).
van der Klift H; Wijnen J; Wagner A; Verkuilen P; Tops C; Otway R; Kohonen-Corish M; Vasen H; Oliani C; Barana D; Moller P; Delozier-Blanchet C; Hutter P; Foulkes W; Lynch H; Burn J; Möslein G; Fodde R
Genes Chromosomes Cancer; 2005 Oct; 44(2):123-38. PubMed ID: 15942939
[TBL] [Abstract][Full Text] [Related]
37. Paediatric intestinal cancer and polyposis due to bi-allelic PMS2 mutations: case series, review and follow-up guidelines.
Herkert JC; Niessen RC; Olderode-Berends MJ; Veenstra-Knol HE; Vos YJ; van der Klift HM; Scheenstra R; Tops CM; Karrenbeld A; Peters FT; Hofstra RM; Kleibeuker JH; Sijmons RH
Eur J Cancer; 2011 May; 47(7):965-82. PubMed ID: 21376568
[TBL] [Abstract][Full Text] [Related]
38. Refining the role of PMS2 in Lynch syndrome: germline mutational analysis improved by comprehensive assessment of variants.
Borràs E; Pineda M; Cadiñanos J; Del Valle J; Brieger A; Hinrichsen I; Cabanillas R; Navarro M; Brunet J; Sanjuan X; Musulen E; van der Klift H; Lázaro C; Plotz G; Blanco I; Capellá G
J Med Genet; 2013 Aug; 50(8):552-63. PubMed ID: 23709753
[TBL] [Abstract][Full Text] [Related]
39. Gastrointestinal Findings in the Largest Series of Patients With Hereditary Biallelic Mismatch Repair Deficiency Syndrome: Report from the International Consortium.
Aronson M; Gallinger S; Cohen Z; Cohen S; Dvir R; Elhasid R; Baris HN; Kariv R; Druker H; Chan H; Ling SC; Kortan P; Holter S; Semotiuk K; Malkin D; Farah R; Sayad A; Heald B; Kalady MF; Penney LS; Rideout AL; Rashid M; Hasadsri L; Pichurin P; Riegert-Johnson D; Campbell B; Bakry D; Al-Rimawi H; Alharbi QK; Alharbi M; Shamvil A; Tabori U; Durno C
Am J Gastroenterol; 2016 Feb; 111(2):275-84. PubMed ID: 26729549
[TBL] [Abstract][Full Text] [Related]
40. PMS2 mutations in childhood cancer.
De Vos M; Hayward BE; Charlton R; Taylor GR; Glaser AW; Picton S; Cole TR; Maher ER; McKeown CM; Mann JR; Yates JR; Baralle D; Rankin J; Bonthron DT; Sheridan E
J Natl Cancer Inst; 2006 Mar; 98(5):358-61. PubMed ID: 16507833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
